JASPER THERAPEUTICS, INC. Earnings Per Share (Basic)
JASPER THERAPEUTICS, INC. (JSPR) reported Earnings Per Share (Basic) of -$0.10 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- JASPER THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.10.
- JASPER THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.04.
- JASPER THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.13.
- JASPER THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.74.
- JASPER THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$3.95.
- JASPER THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$4.89.
- JASPER THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$6.18.
- JASPER THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$10.33.
| Period end | Earnings Per Share, Basic | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.10 10-Q · filed 2026-08-14 | -$0.14 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-14 | ||||||||
| 2025-12-31 | -$3.95 10-K · filed 2026-03-30 | ||||||||
| 2025-09-30 | -$1.13 10-Q · filed 2025-11-10 | -$4.18 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | -$1.74 10-Q · filed 2026-08-14 | -$3.16 10-Q · filed 2026-08-14 | |||||||
| 2025-03-31 | -$1.41 10-Q · filed 2026-05-14 | ||||||||
| 2024-12-31 | -$4.89 10-K · filed 2026-03-30 | ||||||||
| 2024-09-30 | -$1.24 10-Q · filed 2025-11-10 | -$3.25 10-Q · filed 2025-11-10 | |||||||
| 2024-06-30 | -$0.97 10-Q · filed 2025-08-13 | -$2.00 10-Q · filed 2025-08-13 | |||||||
| 2024-03-31 | -$1.03 10-Q · filed 2025-05-12 | ||||||||
| 2023-12-31 | -$6.18 10-K · filed 2025-02-28 | ||||||||
| 2023-09-30 | -$4.68 10-Q · filed 2024-11-07 | -$1.60 10-Q · filed 2024-11-07 | -$0.16 10-Q · filed 2023-11-09 | -$4.68 10-Q · filed 2024-11-07 | -$0.47 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$1.47 10-Q · filed 2024-08-13 | -$0.15 10-Q · filed 2023-08-11 | -$3.08 10-Q · filed 2024-08-13 | -$0.31 10-Q · filed 2023-08-11 | |||||
| 2023-03-31 | -$1.62 10-Q · filed 2024-05-14 | -$0.16 10-Q · filed 2023-05-12 | |||||||
| 2022-12-31 | -$10.33 10-K · filed 2024-03-05 | -$1.03 10-K · filed 2023-03-08 | |||||||
| 2022-09-30 | -$0.32 10-Q · filed 2023-11-09 | -$0.67 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | -$0.29 10-Q · filed 2023-08-11 | -$0.35 10-Q · filed 2023-08-11 | |||||||
| 2022-03-31 | -$0.06 10-Q · filed 2023-05-12 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-05-12 | ||||||
| 2021-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$2.69 10-K · filed 2023-03-08 | ||||||
| 2021-09-30 | -$0.69 10-Q · filed 2022-11-10 | -$7.13 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |